title: [Hepatitis B reactivation with rituximab in an HIV-infected anti-HBs antibody carrier].
authors.affiliation: Service d'hépatogastroentérologie, unité de virologie, centre hospitalier de Versailles, 177, rue de Versailles, 78157 Le Chesnay cedex, France. kbenghalia@ch-versailles.fr
authors.forename: K
authors.initials: K
authors.lastname: Benghalia
authors.forename: S
authors.initials: S
authors.lastname: Roussin-Bretagne
authors.forename: S
authors.initials: S
authors.lastname: Marque-Juillet
authors.forename: P
authors.initials: P
authors.lastname: Colardelle
authors.forename: M
authors.initials: M
authors.lastname: Chochon
authors.forename: M
authors.initials: M
authors.lastname: Harzic
authors.forename: J
authors.initials: J
authors.lastname: Doll
mesh_terms: D000328:Adult; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015658:HIV Infections / Q000097:blood / Q000150:complications; D006509:Hepatitis B / Q000097:blood / Q000139:chemically induced*; D006510:Hepatitis B Antibodies / Q000097:blood; D006801:Humans; D008297:Male; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D006510:Hepatitis B Antibodies; D000069283:Rituximab